DJIA 17,084.49 33.74 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo

87.75 0.45 (0.52%)

Quote as of

company name or ticker

Recent Quotes

GWPH $87.75 0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $86.82
Previous Close $87.30
Daily Range $85.63 - $88.33
52-Week Range $58.16 - $133.98
Market Cap $1.7B
P/E Ratio -145.50
Dividend (Yield) $0.00 (0.0%)
Volume 142,922
Average Daily Volume 301,784
Current FY EPS -$3.87



GW Pharmaceuticals Plc (ADR) (GWPH) Description

GW Pharmaceuticals Plc - American Depositary Shares Website:

News & Commentary Rss Feed

Why GW Pharmaceuticals Dropped 14% in September

Lackluster trial results for its marijuana medicine for schizophrenia contributed to shares falling last month.

World Mental Health Day: De-Stress with 4 Stocks

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

'Mad Money' Lightning Round: Buy, Buy, Buy Blackstone and KKR

Can Marijuana Treat Schizophrenia?

GW Pharmaceuticals' marijuana study in schizophrenia raises questions over how effective cannabidiol is at treating the disease.

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

GW Pharmaceuticals Up on Encouraging Schizophrenia Data

European ADRs Climb Driven by Mining & Oil Majors

GW Pharmaceuticals (GWPH) in Focus: Stock Jumps 7.6%

GW Pharmaceuticals' Schizophrenic Marijuana Drug Data

Read between the press-release headlines.

See More GWPH News...